Singapore, Singapore

Gautam Sethi

This inventor holds 1 USPTO granted patent. Top assignees: Bangalore University, National University of Singapore, University of Cambridge. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gautam Sethi. Retrieved from https://idiyas.com/inventor/gautam-sethi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 17.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Gautam Sethi: Pioneering Innovations in Cancer Treatment

Introduction

Gautam Sethi, a notable inventor based in Singapore, has made significant contributions to the field of oncology through his innovative work. With a focus on the modulation of the JAK-STAT signaling pathway, he has developed methods that could lead to groundbreaking treatments for cancer.

Latest Patents

Sethi holds a patent for "Compounds as Modulator of JAK-STAT Pathway, Methods and Applications Thereof." This patent encompasses compounds outlined in Structural Formula I and presents a method for synthesizing these compounds. The innovation details how these compounds can be employed to manipulate the JAK-STAT pathway in cancer cells, positioning them as potential anti-cancer agents.

Career Highlights

Throughout his career, Gautam Sethi has been associated with reputable institutions, including the University of Mysore and the National University of Singapore. His experiences in these academic environments have greatly influenced his research focus and innovative approaches.

Collaborations

In his professional journey, Sethi has collaborated with esteemed colleagues such as Kanchugarakoppal Subbegowda Rangappa and Basappa. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Gautam Sethi's work in cancer research is a testament to his dedication as an inventor. His patent on JAK-STAT pathway modulation not only reflects his innovative spirit but also holds promise for advancements in cancer treatment. As research in this area evolves, Sethi's contributions may pave the way for new therapeutic options in oncology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…